Trademark: 88920922
Status Date
Monday, May 29, 2023
Filing Date
Monday, May 18, 2020
Published for Opposition
Tuesday, March 2, 2021
Abandoned Date
Monday, May 29, 2023
5 Medical diagnostic test that employs in vitro assays for analyzing cancer cells to identify specific biological drivers of the cancer; medical cell based assays for testing cancer cells for use in selecting therapeutics in the treatment of cancer
May 30, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
May 29, 2023
Abandonment - No Use Statement Filed
Oct 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2022
Sou Extension 3 Granted
Oct 27, 2022
Sou Extension 3 Filed
Oct 27, 2022
Sou Teas Extension Received
Apr 28, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 26, 2022
Sou Extension 2 Granted
Apr 26, 2022
Sou Extension 2 Filed
Apr 26, 2022
Sou Teas Extension Received
Oct 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2021
Sou Extension 1 Granted
Oct 27, 2021
Sou Extension 1 Filed
Oct 27, 2021
Sou Teas Extension Received
Apr 27, 2021
Noa E-Mailed - Sou Required From Applicant
Mar 2, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 2, 2021
Published For Opposition
Feb 10, 2021
Notification Of Notice Of Publication E-Mailed
Jan 25, 2021
Approved For Pub - Principal Register
Jan 13, 2021
Examiner's Amendment Entered
Jan 13, 2021
Assigned To Lie
Jan 13, 2021
Notification Of Examiners Amendment E-Mailed
Jan 13, 2021
Examiners Amendment E-Mailed
Jan 13, 2021
Examiners Amendment -Written
Dec 14, 2020
Teas/Email Correspondence Entered
Dec 14, 2020
Correspondence Received In Law Office
Dec 14, 2020
Teas Response To Office Action Received
Aug 21, 2020
Notification Of Non-Final Action E-Mailed
Aug 21, 2020
Non-Final Action E-Mailed
Aug 21, 2020
Non-Final Action Written
Aug 17, 2020
Assigned To Examiner
Jun 2, 2020
New Application Office Supplied Data Entered
May 21, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
